Andrea Miller, DO
Obstetrics & Gynecology · Moore, OKNPI 1639372899
Payments from drug & device makers
Across 111 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$509
- Novo Nordisk$110
- Mayne Pharma Commercial LLC$106
- Sage Therapeutics, LLC$104
- Pfizer$97
- Organon$95
- plus $883 from 23 others
What the payments were for
- Food & beverage$1,905100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $509 |
| Novo Nordisk | 7 | $110 |
| Mayne Pharma Commercial LLC | 6 | $106 |
| Sage Therapeutics, LLC | 6 | $104 |
| Pfizer | 6 | $97 |
| Organon | 5 | $95 |
| Roche Diagnostics Corporation | 5 | $91 |
| Bayer | 5 | $90 |
| Therapeuticsmd, Inc. | 6 | $89 |
| Astellas Pharma US Inc | 4 | $70 |
| Hologic Sales And Service, LLC | 3 | $63 |
| Medtronic | 2 | $61 |
| Pacira Pharmaceuticals Incorporated | 3 | $54 |
| Exeltis, USA Inc. | 3 | $44 |
| Minerva Surgical, Inc | 1 | $37 |
| Amgen | 2 | $30 |
| Merck | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Coopersurgical, Inc. | 1 | $28 |
| Avion Pharmaceuticals | 2 | $27 |
| AstraZeneca | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Agile Therapeutics, Inc. | 1 | $17 |
| GSK | 1 | $15 |
| Abbott | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Scynexis, Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
How this compares
$1,905 in reported general payments places this provider in the 60th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $4,314 |
| YuvafemEstradiol | 18 | $3,453 |
| ValacyclovirValacyclovir Hcl | 11 | $550 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Moore
- Kathleen MooreOklahoma City$11.1M
- Tori OdanielOklahoma City$917K
- Joseph NemcokTulsa$632K
- James WaymanMuskogee$452K
- Calvin MonroeTulsa$219K
- Jay WilliamsonTulsa$130K
- Corey JacobsElk City$63K
- John SiegleAda$50K
- Lori HubbardTulsa$41K
- Dawn WilsonYukon$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.